News

Portfolio Companies
in the News

Reneo Pharmaceuticals Announces First Patient Dosed in the STRIDE Study

July 28, 2021

Arbutus Biopharma and Antios Therapeutics Announce Clinical Collaboration Agreement to Evaluate AB-729 in Combination with ATI-2173 in Subjects with Chronic Hepatitis B Virus Infection

June 29, 2021

Reneo Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices

June 29, 2021

Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System

June 29, 2021

4D Molecular Therapeutics Announces Rare Disease Ophthalmology Product Candidate Portfolio Update, Including Initial Clinical Safety and Tolerability Data for 4D-110 for Choroideremia and 4D-125 for XLRP, and Termination of Roche Collaboration and License

June 24, 2021

Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

June 24, 2021

Antios Therapeutics’ ATI-2173 Demonstrates Potent Antiviral Activity and Evidence of Off-Treatment Sustained Viral Suppression in Chronic HBV Patients

June 23, 2021

Contego Medical, Inc. announced receipt of CE Mark approval for the Neuroguard IEP®

April 16, 2021

Impulse Dynamics Receives Approval to Sell Optimizer CCM Devices in China

February 22, 2021

category

Medtech

Status

Current

headquarters

Halifax, Nova Scotia

website

Sound Blade Medical

Sound Blade Medical is a medical device company that is developing handheld ultrasound-guided histotripsy technology to treat a wide range of conditions. Histotripsy is a non-invasive, non-thermal ablation technology to selectively destroy tissue with unparalleled precision.

category

medtech

status

Current

headquarters

Plymouth, Minnesota

website

HistoSonics

HistoSonics has developed a system to destroy tumors completely non-invasively. Treatment is achieved using histotripsy, a novel form of energy that is safe, extremely precise, and able to be personalized for each patient. The initial indication is for treatment of liver tumors and the system is being studied in several other types of tumors.

category

MEDTECH

status

Exited/Public

headquarters

Redwood City, California

website

Gynesonics

Gynesonics is a medical device company committed to advancing women’s health by developing transcervical, uterus-preserving, incisionless technologies for diagnostic and therapeutic applications. The company’s Sonata system is the world’s first and only intrauterine fibroid ablation system clinically proven to reduce fibroid symptoms across a wide range of fibroid types, sizes, and uterine locations.